Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of American Academy of Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaad.2016.01.062PMID 27986132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid‐Induced Osteoporosis

  2018cited by this paper
• Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

  2016cited by this paper
• Stress Dose Steroids: Myths and Perioperative Medicine

  2016cited by this paper
• Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

  2016cited by this paper
• Bisphosphonates for steroid-induced osteoporosis.

  2016cited by this paper
• Bisphosphonates and glucocorticoid-induced osteoporosis: cons

  2015cited by this paper
• American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

  2015cited by this paper
• Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

  2015cited by this paper
• Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

  2015cited by this paper
• Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.

  2014cited by this paper
• 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

  2014cited by this paper
• Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

  2014cited by this paper
• Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

  2014cited by this paper
• The medically immunocompromised adult traveler and pre-travel counseling: status quo 2014.

  2014cited by this paper
• United States Adults Meeting 2010 American College of Rheumatology Criteria for Treatment and Prevention of Glucocorticoid‐Induced Osteoporosis

  2014cited by this paper
• Medication-Related Osteonecrosis of the Jaw—2014 Update

  2014cited by this paper
• Rheumatological patients undergoing immunosuppressive treatments and parasitic diseases: a review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.

  2014cited by this paper
• Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

  2014cited by this paper
• Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases

  2014cited by this paper
• Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Does low‐dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

  2014cited by this paper
• Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

  2014cited by this paper
• Novel Assessment Tools for Osteoporosis Diagnosis and Treatment

  2014cited by this paper
• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014

  2014cited by this paper
• Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy

  2014cited by this paper
• Proton pump inhibitor therapy and potential long-term harm

  2014cited by this paper
• Vaccination in Solid Organ Transplantation

  2013cited by this paper
• Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

  2013cited by this paper
• Infection in autoimmune bullous diseases: A retrospective comparative study

  2013cited by this paper
• Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.

  2013cited by this paper
• Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

  2013cited by this paper
• Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study

  2013cited by this paper
• Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.

  2013cited by this paper
• Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.

  2013cited by this paper
• How should I interpret an interferon gamma release assay result for tuberculosis infection?

  2013cited by this paper
• [Concomitant use of proton pump inhibitors and systemic corticosteroids].

  2013cited by this paper
• Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey.

  2013cited by this paper
• Safety of bisphosphonates.

  2012cited by this paper
• Recent safety concerns with proton pump inhibitors.

  2012cited by this paper
• Glucocorticoid-induced osteoporosis and osteonecrosis.

  2012cited by this paper
• Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis

  2012cited by this paper
• Glucocorticoid-induced hypertension

  2012cited by this paper
• Benefits and risks of bisphosphonate therapy for osteoporosis.

  2012cited by this paper
• Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care.

  2012cited by this paper
• Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study

  2012cited by this paper
• Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study

  2012cited by this paper
• [Reactivation of hepatitis B infection due to glucocorticoids].

  2011cited by this paper
• Risk factors for medication-induced diabetes and type 2 diabetes.

  2011cited by this paper
• Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study

  2011cited by this paper
• Uncertainties in the prevention and treatment of glucocorticoid‐induced osteoporosis

  2011cited by this paper
• American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

  2011cited by this paper
• The Immunogenicity and Safety of Live Attenuated Varicella-zoster Virus Vaccine in Human Immunodeficiency Virus-infected Children

  2011cited by this paper
• Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

  2011cited by this paper
• Glucocorticoid-induced myopathy.

  2011cited by this paper
• Steroid myopathy: Some unresolved issues

  2011cited by this paper
• Safety of bisphosphonates.

  2011cited by this paper
• Clinical practice. Glucocorticoid-induced bone disease.

  2011influential reference
• The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)

  2011cited by this paper
• Psychiatric complications of treatment with corticosteroids: Review with case report

  2011cited by this paper
• Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study

  2011cited by this paper
• Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications

  2011cited by this paper
• Preventing vitamin D toxicity in patients with sarcoidosis.

  2011cited by this paper
• Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs.

  2011influential reference
• Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD.

  2011cited by this paper
• Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

  2011cited by this paper
• Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions.

  2010cited by this paper
• Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications.

  2010cited by this paper
• Systemic corticosteroid and reactivation of chronic hepatitis B

  2010cited by this paper
• Steroid induced osteonecrosis: An analysis of steroid dosing risk

  2010cited by this paper
• Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression.

  2010cited by this paper
• Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids

  2010cited by this paper
• Adrenal insufficiency: etiology, diagnosis and treatment

  2010cited by this paper
• EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  2010cited by this paper
• Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.

  2009cited by this paper
• Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

  2009cited by this paper
• Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.

  2009cited by this paper
• Glucocorticoids

  2009cited by this paper
• Systemic effects of intra-articular corticosteroids

  2009cited by this paper
• Long-term corticosteroid use.

  2009cited by this paper
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.

  2009cited by this paper
• Effects of Glucocorticoids on Mood, Memory, and the Hippocampus

  2009cited by this paper
• Glucocorticoid-mediated hypertension: does the vascular smooth muscle hold all the answers?

  2008cited by this paper
• Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

  2008cited by this paper
• Mechanisms of glucocorticoid-induced myopathy.

  2008cited by this paper
• [Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier].

  2008cited by this paper
• Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

  2008cited by this paper
• Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results.

  2008cited by this paper
• Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease

  2008cited by this paper
• Corticosteroid physiology and principles of therapy

  2008cited by this paper
• Dose-related patterns of glucocorticoid-induced side effects

  2008cited by this paper
• Strongyloides hyperinfection syndrome: an emerging global infectious disease.

  2008cited by this paper
• Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.

  2007cited by this paper
• Glucocorticoid-induced osteoporosis: pathophysiology and therapy

  2007cited by this paper
• Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy

  2007cited by this paper
• Fracture risk with intermittent high-dose oral glucocorticoid therapy.

  2007cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood

  2007cited by this paper
• Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases.

  2007cited by this paper
• EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  2007cited by this paper

• Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study.

  2026cites this paper
• Senear–Usher Syndrome or Coexistence of SLE with Pemphigus Vulgaris—A Case Report with Literature Review

  2025cites this paper
• Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature

  2025cites this paper
• Research Advances in the Impact of Probiotic Supplementation on Ulcerative Colitis Management

  2025cites this paper
• Therapeutic potential of mesenchymal stem cell-based therapy for inflammatory bowel disease: Current advances and future perspectives.

  2025cites this paper
• Nail Lichen Planus: A Comprehensive Review of Clinical Features, Histopathology, and Current Treatment

  2025cites this paper
• Triamcinolone-loaded nanocarriers: a novel strategy to mitigate cognitive and emotional sequelae induced by traumatic brain injury via modulation of oxidative stress

  2025cites this paper
• Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases

  2025cites this paper
• The Role of Antidiabetic Drugs in Bone Health: Assessing the Risk of Osteoporosis Subtypes and Fractures Using Mendelian Randomization

  2025cites this paper
• Total Femoral Head Collapse in a Corticosteroid-Induced Pathologic Fracture

  2025cites this paper
• Rethinking corticosteroids use in oncology

  2025cites this paper
• Sarcoidosis for the Inpatient Dermatologist

  2025cites this paper
• Echinacoside alleviates glucocorticoid induce osteonecrosis of femoral head in rats through PI3K/AKT/FOXO1 pathway.

  2024cites this paper
• Efeitos adversos da corticoterapia sistêmica crônica: o que o dermatologista deve saber

  2024cites this paper
• Role of PI3K/AKT/MAOA in glucocorticoid‐induced oxidative stress and associated premature senescence of the trabecular meshwork

  2024cites this paper
• II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata

  2024cites this paper
• Delayed-Onset Isolated ICI (pembrolizumab)-Associated Gastritis with Concomitant Intussusception.

  2024cites this paper
• Mitochondrial maintenance as a novel target for treating steroid-induced osteonecrosis of femoral head: a narrative review

  2024cites this paper
• Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids

  2024cites this paper
• Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis.

  2024cites this paper
• FeNO, a potential biomarker for evaluating glucocorticoids treatment and prognosis in ABPA.

  2024cites this paper
• The molecular subtypes of autoimmune diseases

  2024cites this paper
• Harnessing self-assembled nanoplatform of Dexamethasone and α-linolenic acid for high-efficiency inhibition of pulmonary cytokine storm and fibrosis in mice

  2024cites this paper
• Dose-Adjusted FRAX Score in Pemphigus Vulgaris Treatment

  2024cites this paper
• Emerging nanoparticle platforms to improve the administration of glucocorticoids.

  2023cites this paper
• Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)

  2023cites this paper
• Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know

  2023cites this paper
• Agomelatine alleviates steroid‐induced osteoporosis by targeting SIRT1/RANKL/FOXO1/OPG signalling in rats

  2023cites this paper
• Causal relationship between breakfast skipping and bone mineral density: a two-sample Mendelian randomized study

  2023cites this paper
• Overview of Brain Metastasis and Treatment Modalities

  2023cites this paper
• Significant symptom resolution of spinal lipomatosis with weight loss

  2023cites this paper
• Impact of glucocorticoid replacement therapy on bone mineral density in adults with Addison disease

  2023cites this paper
• Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of FcγRI

  2023cites this paper
• Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.

  2023cites this paper
• Carboxymethyl chitosan regulates macrophages polarization to inhibit early subconjunctival inflammation in conjunctival injury.

  2023cites this paper
• Dermatomyositis Diagnosis and Treatment in the Inpatient Setting

  2023cites this paper
• Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease

  2023cites this paper
• Development of triamcinolone acetonide-hyaluronic acid conjugates with selective targeting and less osteoporosis effect for rheumatoid arthritis treatments.

  2023cites this paper
• Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)

  2023influential citation
• Efficacy and safety of glucocorticoid in the treatment of sepsis: A systematic review and meta-analysis.

  2023cites this paper
• Current Progress in Treating Systemic Lupus Erythematosus Using Exosomes/MicroRNAs

  2023cites this paper
• Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.

  2023cites this paper
• Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway

  2022cites this paper
• Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging

  2022cites this paper
• Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial

  2022cites this paper
• Treatment of cutaneous vasculitis

  2022cites this paper
• Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting.

  2022cites this paper
• Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management

  2022cites this paper
• Systemic glucocorticoid prescriptions pattern and factors of inappropriate use in primary care institutions of Southwest China

  2022cites this paper
• Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis

  2022cites this paper
• Autocrine Activity of Extracellular Vesicles Induced by Icariin and Its Effectiveness in Glucocorticoid-Induced Injury of Bone Microvascular Endothelial Cells

  2022cites this paper
• Neuroendocrine–Immune Regulatory Network of Eucommia ulmoides Oliver

  2022cites this paper
• Dexamethasone and ketorolac compare with ketorolac alone in acute renal colic: A randomized clinical trial.

  2022cites this paper
• A New Subform? Fast-Progressing, Severe Neurological Deterioration Caused by Spinal Epidural Lipomatosis

  2022cites this paper
• Glucocorticoids induce osteonecrosis of the femoral head in rats via PI3K/AKT/FOXO1 signaling pathway

  2022cites this paper
• Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study

  2022cites this paper
• The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

  2022cites this paper
• Anticoagulants and corticosteroids in COVID-19: What do we know so far?

  2022cites this paper
• Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head.

  2022cites this paper
• Novel CuO/Mn3O4/ZnO nanocomposite with superior photocatalytic activity for removal of Rabeprazole from water

  2021cites this paper
• Drugs for the Skinternist

  2021cites this paper
• Preventive Effects of Dietaryraisins on Steroid - Induced Bone Changes in Rats

  2021cites this paper
• Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report

  2021cites this paper
• Advances in cutaneous vasculitis research and clinical care

  2021cites this paper
• When Mind Meets the Brain: Essentials of Well-Coordinated Management of Psychiatric Disorders in Neurological Diseases.

  2021cites this paper
• Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages

  2021cites this paper
• Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series

  2021cites this paper
• Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes

  2021influential citation
• Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Management der Glukokortikoid-induzierten Osteoporose

  2021cites this paper
• Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern

  2021cites this paper
• Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

  2021cites this paper
• German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis

  2021cites this paper
• Persistent Hyperglycemia in Brain Tumor Patients Treated with Dexamethasone Peri-Operatively and Post-Operatively

  2021cites this paper
• Secondary Osteoporosis

  2021cites this paper
• Systemic Corticosteroids

  2021cites this paper
• Autocrine Activity of Exosomes in Glucocorticoid-Induced Injury of Bone Microvascular Endothelial Cells Identified by Protein Array

  2021cites this paper
• CircRNA–miRNA networks in regulating bone disease

  2021cites this paper
• Tanshinone I Mitigates Steroid-Induced Osteonecrosis of the Femoral Head and Activates the Nrf2 Signaling Pathway in Rats

  2021cites this paper
• Blood tyrosine determination for monitoring glucocorticoid therapy

  2021cites this paper
• Unconventional Pain Management for People With Systemic Lupus Erythematosus: A Systematic Literature Review

  2020cites this paper
• Cutaneous Sarcoidosis

  2020cites this paper
• The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review

  2020cites this paper
• Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis

  2020cites this paper
• Prevalence and Predictors of Compromised Bone Mineral Density in Pediatric Eosinophilic Esophagitis

  2020cites this paper
• Management of Cutaneous Vasculitis.

  2020cites this paper
• Lichenoid Reaction Caused by Antihistamines and Corticosteroids

  2020cites this paper
• Glucocorticoid treatment exacerbates mycobacterial infection by reducing the phagocytic capacity of macrophages Glucocorticoids and zebrafish TB

  2020cites this paper
• Effects of hypoxia environment on osteonecrosis of the femoral head in Sprague-Dawley rats

  2020cites this paper
• Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases

  2020cites this paper
• Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize

  2020cites this paper
• Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

  2020cites this paper
• Autoimmune bullous skin diseases, pemphigus and pemphigoid.

  2020cites this paper
• PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway

  2020cites this paper
• Isolated Nail Lichen Planus- an expert consensus on treatment of the classical form.

  2020cites this paper
• Glucocorticoid prescribing habits of sports medicine physicians working in high-performance sport: a 30-nation survey

  2020cites this paper
• Orale Glukokortikoide

  2020cites this paper
• A butanolic fraction from the standardized stem extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophy

  2020cites this paper
• Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology⋆⋆⋆

  2020cites this paper
• Rosacea and Neurological Comorbidities

  2020cites this paper
• Pancreatic manifestations in rheumatoid arthritis: a national population-based study.

  2020cites this paper